Naftopidil hydrochloride

TargetMol
Product Code: TAR-T9220
Supplier: TargetMol
CodeSizePrice
TAR-T9220-1mg1mg£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-2mg2mg£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-5mg5mg£176.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-1mL1 mL * 10 mM (in DMSO)£201.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-10mg10mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-25mg25mg£356.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-50mg50mg£499.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-100mg100mg£688.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9220-500mg500mg£1,340.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Naftopidil hydrochloride is a selective alpha1-adrenoceptor antagonist with Ki of 3.7 nM, 20 nM and 1.2 nM for the cloned human α1a-adrenoceptor, α1b-adrenoceptor and α1d-adrenoceptor, respectively. Naftopidil hydrochloride has antiproliferative effects.
CAS:
1164469-60-6
Formula:
C24H29ClN2O3
Molecular Weight:
428.96
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.9995
SMILES:
Cl.COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
Target:
Adrenergic Receptor

References

Urushiyama H , Y Terasaki, Nagasaka S , et al. Naftopidil reduced the proliferation of lung fibroblasts and bleomycin?nduced lung fibrosis in mice[J]. Journal of Cellular and Molecular Medicine, 2019. Y, Hori, K, et al. Naftopidil, a Selective 1-Adrenoceptor Antagonist, Suppresses Human Prostate Tumor Growth by Altering Interactions between Tumor Cells and Stroma[J]. Cancer Prevention Research, 2011, 4(1).